Internal Medicine, Nephrology · Los Angeles, CA
NPI
1093767337
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
6222 Wilshire Blvd Ste 304
Los Angeles, CA, 90048
Phone (310) 733-4171
Groups this clinician bills Medicare through
Medicare paid, 2024
$480K
5,071 services
Medicare patients, 2024
260
Average age 72
Drug cost, 2024
$1.1M
8,740 prescriptions
Company payments, 2025
$453
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pagiel Shechter was code 99233 (hospital e&m - subsequent), 964 times for 111 patients. In total Pagiel Shechter billed 5,071 services in 43 codes, and Medicare paid $480K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 964 | 111 | $102.78 | $99K |
| 99497 Care Management/Coordination | Office | 950 | 145 | $70.15 | $67K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 718 | 140 | $55.96 | $40K |
| 99349 Home E&M - New and Established | Office | 363 | 52 | $103.27 | $37K |
| 99214 Office E&M - Established | Office | 297 | 89 | $109.02 | $32K |
| 99215 Office E&M - Established | Office | 274 | 61 | $156.77 | $43K |
| 90935 Hemodialysis | Facility | 201 | 29 | $61.45 | $12K |
| 99309 SNF E&M | Facility | 162 | 45 | $93.92 | $15K |
| 99223 Hospital E&M - Initial | Facility | 145 | 93 | $149.51 | $22K |
| 93306 Echocardiography (TTE/TEE) | Office | 141 | 79 | $186.33 | $26K |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 138 | 62 | $46.19 | $6,374 |
| 99497 Care Management/Coordination | Facility | 137 | 64 | $65.31 | $8,948 |
| 99239 Hospital Discharge Management | Facility | 124 | 75 | $100.65 | $12K |
| 99350 Home E&M - New and Established | Office | 104 | 36 | $155.48 | $16K |
| 90960 ESRD Related Services (not dialysis) | Office | 60 | 19 | $297.70 | $18K |
By year: 2022 $305K for 3,449 services; 2023 $448K for 4,652 services; 2024 $480K for 5,071 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pagiel Shechter prescribed most often to Medicare patients was Amlodipine Besylate, with 544 prescriptions and refills. In total Pagiel Shechter wrote 8,740 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 544 | 649 | 80 | $3,281 |
| Labetalol Hcl Generic | 475 | 601 | 65 | $13K |
| Atorvastatin Calcium Generic | 340 | 422 | 51 | $4,025 |
| Tamsulosin Hcl Generic | 245 | 258 | 29 | $2,999 |
| Rosuvastatin Calcium Generic | 244 | 333 | 36 | $5,390 |
| Eliquis Apixaban | 234 | 244 | 30 | $89K |
| Irbesartan Generic | 231 | 308 | 39 | $4,935 |
| Pantoprazole Sodium Generic | 207 | 235 | 43 | $7,419 |
| Gabapentin Generic | 198 | 210 | 28 | $2,561 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 171 | 171 | 41 | $3,175 |
| Levothyroxine Sodium Generic | 162 | 218 | 27 | $1,618 |
| Carvedilol Generic | 146 | 194 | 25 | $1,037 |
| Famotidine Generic | 142 | 149 | 22 | $1,199 |
| Jardiance Empagliflozin | 131 | 151 | 16 | $75K |
| Metoprolol Succinate Generic | 118 | 150 | 21 | $2,475 |
Brand drugs: 1,373 claims; generic drugs: 7,225 claims; opioid claims: 320.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pagiel Shechter $453 ($453 in general payments such as food, travel and fees) from 8 companies. The largest payer was Ardelyx, Inc. with $172.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 12 | $172 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $75.87 |
| OPKO Pharmaceuticals, LLC | 2 | $46.78 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $39.86 |
| Calliditas Therapeutics US Inc. | 1 | $37.9 |
| Novo Nordisk Inc NVO | 1 | $32.1 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $30.23 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $18.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.